Yu K Peony 4
4 · FIBROGEN INC · Filed Sep 4, 2020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Yu K Peony
VP, Clinical Development
Transactions
- Exercise/Conversion
Common Stock
2020-09-03$18.00/sh+10,000$180,000→ 215,576 total - Sale
Common Stock
2020-09-03$50.89/sh−10,000$508,900→ 205,576 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-03−10,000→ 42,500 totalExercise: $18.00Exp: 2024-11-13→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]Fully vested.